James Van Der Beek said years before his death he got 'almost nothing' from Dawson's Creek residuals
James Van Der Beek previously opened up about how he got "almost nothing" from Dawson's Creek residuals, which helps explain why his family is currently struggling financially in the wake of his death ...
Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. Quest Flow ...
SECAUCUS, N.J. - Quest Diagnostics (NYSE:DGX) introduced a new blood test on Monday that detects measurable residual disease (MRD) in myeloma patients using advanced flow cytometry methods. The ...
SECAUCUS, N.J., Feb. 2, 2026 /PRNewswire/ --Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel blood test that uses advanced ...
"Our Flow Cytometry MRD for Myeloma test harnesses cutting-edge science and technology to deliver ultrasensitive insights from a noninvasive blood test, thereby improving care and value for patients ...
PALO ALTO, Calif. & ROCHESTER, Minn., February 02, 2026--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company and research collaborators at Mayo Clinic and the ...
TROY, Mich.: 20 Jan. 2026 — In a market where affordability pressures are pushing more customers to weigh the total cost of vehicle ownership, the estimated worth of a vehicle at the end of its lease ...
Abstract: This paper presents PyResBugs, a curated dataset of residual bugs, i.e., defects that persist undetected during traditional testing but later surface in production—collected from major ...
Residuals are one of the most essential forms of compensation for DGA members. They ensure that when work continues to generate revenue over time, the people who made it possible share in that ongoing ...
Minimal residual disease (MRD) testing—using circulating tumor DNA (ctDNA) to detect minute traces of cancer after treatment—is generating increased interest in the management of solid tumors. As ...
Data support routine use of circulating tumor DNA testing in management of stage III colon cancer patients Tumor fraction analysis provides further insights for patient management in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results